<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</sup> PFU of rAd/NP. Control mice were immunized intranasally with rAd/Mock. Mice that received rAd/NP via sublingual route were boosted two weeks after the primary vaccination. Subsequently mice in all vaccination groups were challenged intranasally with 10 LD<sub>50</sub> of PR8 virus three weeks after their last immunization. (A) At day 5 post-challenge, lung cells were harvested from mice (n = 5) in each group and stained with K <sup>d</sup>/NP<sub>147-155</sub> tetramer, anti-CD8, and anti-CD44 antibody. The percentage of K <sup>d</sup>/NP<sub>147-155</sub> tetramer-positive, CD44-positive cells among total lung CD8-positive cell populati...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>To determine if CD8+ T cells alone can mediate influenza protection, mice were primed using diffe...
<p>C57BL/6 mice were immunized intranasally with 1, 3, or 10 μg of HA-equivalent of BPL-inactivated ...
<p>BALB/c mice were immunized i.m. twice, 8 weeks apart, with PBS, 0.1 μg of SAM(NP), SAM(M1), SAM(M...
<p>The BALB/c mice immunized with 1×10<sup>7</sup> or 1×10<sup>8</sup> PFU of rAd/NP were challenged...
<p>(<b>A–E</b>) BALB/c mice were infected with PR8 (0.1LD<sub>50</sub>) i.n. (<b>A</b>) Absolute num...
<p>Mice were immunised once by the i.n. (A), s.c. (B) or i.m. (C) routes with 10 nmol lipopeptide (L...
<p>(A–I) Indicated groups of mice were infected i.t. with PR8 influenza virus (50 pfu unless otherwi...
<p>WT and p110γ-KD mice were infected with 50 pfu PR8 IAV and the T cell response was analysed at da...
<p>WT and β6 KO mice were infected with influenza as described in <a href="http://www.plospathogens....
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>B6 mice were immunized i.m. in both hind-legs with PBS or a total of 10 µg of NP protein delivere...
<p>B6 (WT) or IDO1-KO mice with B6 backgrounds were infected with PR8 virus (50 PFU, i/n) at sub-let...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> or 1×10<sup>8</sup>...
<p>(A–F) Virus-specific ASC frequencies. DR1 (A–C) and B10 (D–F) mice were infected intranasally wit...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>To determine if CD8+ T cells alone can mediate influenza protection, mice were primed using diffe...
<p>C57BL/6 mice were immunized intranasally with 1, 3, or 10 μg of HA-equivalent of BPL-inactivated ...
<p>BALB/c mice were immunized i.m. twice, 8 weeks apart, with PBS, 0.1 μg of SAM(NP), SAM(M1), SAM(M...
<p>The BALB/c mice immunized with 1×10<sup>7</sup> or 1×10<sup>8</sup> PFU of rAd/NP were challenged...
<p>(<b>A–E</b>) BALB/c mice were infected with PR8 (0.1LD<sub>50</sub>) i.n. (<b>A</b>) Absolute num...
<p>Mice were immunised once by the i.n. (A), s.c. (B) or i.m. (C) routes with 10 nmol lipopeptide (L...
<p>(A–I) Indicated groups of mice were infected i.t. with PR8 influenza virus (50 pfu unless otherwi...
<p>WT and p110γ-KD mice were infected with 50 pfu PR8 IAV and the T cell response was analysed at da...
<p>WT and β6 KO mice were infected with influenza as described in <a href="http://www.plospathogens....
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>B6 mice were immunized i.m. in both hind-legs with PBS or a total of 10 µg of NP protein delivere...
<p>B6 (WT) or IDO1-KO mice with B6 backgrounds were infected with PR8 virus (50 PFU, i/n) at sub-let...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> or 1×10<sup>8</sup>...
<p>(A–F) Virus-specific ASC frequencies. DR1 (A–C) and B10 (D–F) mice were infected intranasally wit...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>To determine if CD8+ T cells alone can mediate influenza protection, mice were primed using diffe...
<p>C57BL/6 mice were immunized intranasally with 1, 3, or 10 μg of HA-equivalent of BPL-inactivated ...